«Pulmicort" has anti-inflammatory effect in the bronchi, reduces the severity of symptoms and exacerbations of asthma, reduces swelling of the bronchial mucosa, sputum or mucus production.With long-term use of the drug is well tolerated, after inhalation of a therapeutic effect lasts for several hours.The maximum therapeutic effect is achieved after one to two weeks.
dose "Pulmicort" for inhalation is set individually.If it does not exceed 1 mg per day, it is necessary to introduce a time.A higher dose is divided into two steps.The initial dose for adults is 1-2 mg per day maintenance - 0.5-4 mg per day.The initial dosage for children aged from six months of 0.25-0.5 mg per day, supporting - 0.25-2 mg per day.
«Pulmicort" not indicated for child
ren under the age of six months, in case of hypersensitivity to budesonide.With care prescribe a drug in liver cirrhosis, active pulmonary tuberculosis, viral, bacterial and fungal infections of the respiratory system.During pregnancy "Pulmicort" should be used minimally acceptable doses.During lakatatsii allowed to use the drug at therapeutic doses.
«Pulmicort" may have the following side effects: dry mouth, irritation of the oropharynx, coughing, hoarseness, candidiasis of the oropharynx, headache, bronchospasm, angioedema, urticaria, skin rashes, contact dermatitis, nervousness, irritability, depression, behavioral disorders.The preparation can also lead to adrenal hypofunction, irritate skin and bruising on the skin (in the case of a mask with a nebulizer).
In acute overdose "Pulmicort" clinical manifestations arise.In the case of using the drug for a long time in high doses may adrenal suppression and Cushing's appearance.The therapeutic effect "Pulmicort" reduce "Phenobarbital" "phenytoin" and "Rifampicin".Effect of the drug increases "Metandrostenol" estrogens, beta adrenostimulyatorov.Provisional inhaled beta-agonists enhances bronchial improves delivery to the respiratory tract of budesonide and enhances its therapeutic effect.Budesonide Interaction with other drugs used in the treatment of asthma have been identified.